To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene C19orf24TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
104 supporting clones for gene C19orf24 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
DN990418 brain, whole brain .a 1 to 623 1 to 623 exact tiling clone,   623/623
(100 %)
4 diff
(99.4 %id)
CR610772 T cells (Jurkat cell line) Cot10-normalized .a 84 to 962 1 to 879 exact     879/879
(100 %)
0 diff
(100 %id)
AL558482 T cells from T cell leukemia .a 84 to 962 1 to 881 E28X A29X V37X T38H L39V ...     881/881
(100 %)
6 diff
(99.4 %id)
BX402818   .a 84 to 915 1 to 834 V37G T38H L39V S40V P41A ...     834/834
(100 %)
4 diff
(99.6 %id)
NM_017914.3   .a 84 to 977 1 to 894 exact RefSeq, AAA   894/894
(100 %)
0 diff
(100 %id)
BP304017   .a 100 to 675 1 to 576 exact     576/576
(100 %)
2 diff
(99.7 %id)
BG333480 melanotic melanoma, skin .a 104 to 623 1 to 520 exact     520/520
(100 %)
4 diff
(99.3 %id)
CB993867 placenta, pre-eclamptic placenta .a 105 to 793 28 to 726 exact     699/825
(84 %)
26 diff
(96.9 %id)
BM042672 melanotic melanoma, cell line, skin .a 106 to 911 813 to 1 P3V L6V Q7P P8A P9A ...     813/816
(99 %)
24 diff
(97.1 %id)
BQ677303 melanotic melanoma, cell line, skin .a 106 to 523 1 to 418       418/1104
(37 %)
7 diff
(99.4 %id)
BQ683353 melanotic melanoma, cell line, skin .a 106 to 647 1 to 544 L70P F80L R91P K96N K97N ...     544/1263
(43 %)
34 diff
(97.4 %id)
BF975228 B-cells, primary B-cells from tonsils (cell line) .a 111 to 867 1 to 741 L11R L12A L13A L14P L15A ...     741/894
(82 %)
34 diff
(96.2 %id)
BM809459 amelanotic melanoma, cell line, skin .a 111 to 743 18 to 662 G2R P3R R4A V5C L6C ...     645/1305
(49 %)
31 diff
(97.7 %id)
BF969640 adrenal cortex carcinoma, cell line, adrenal gland .a 114 to 950 12 to 854       843/897
(93 %)
58 diff
(93.6 %id)
BU177206 melanotic melanoma, skin .a 114 to 930 12 to 834       823/915
(89 %)
18 diff
(98.1 %id)
BU193757 melanotic melanoma, skin .a 114 to 967 12 to 874       863/959
(89 %)
29 diff
(97.0 %id)
BC000890 Cervix, carcinoma .a 115 to 961 1 to 847   available from MGC, AAA   847/847
(100 %)
1 diff
(99.9 %id)
BM967135 Islets of Langerhans, Pancreas .a 116 to 644 1 to 529       529/529
(100 %)
1 diff
(99.9 %id)
BG763390 melanotic melanoma, high MDR (cell line), skin .a 117 to 916 1 to 793       793/795
(99 %)
21 diff
(97.4 %id)
BU508220 leiomyosarcoma, uterus .a 117 to 977 1 to 874       874/880
(99 %)
18 diff
(98.0 %id)
BI259575 cervical carcinoma cell line, cervix .a 122 to 855 1 to 732       732/734
(99 %)
17 diff
(97.7 %id)
AA234535.
matches multiple genes
mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 123 to 513 1 to 384     also hits gene CLTA 384/389
(98 %)
14 diff
(96.5 %id)
AA292217 ovarian tumor, ovary .a 124 to 703 1 to 570       570/570
(100 %)
34 diff
(94.1 %id)
CR984482 T-Lymphocytes .a 124 to 869 1 to 746       746/750
(99 %)
2 diff
(99.8 %id)
AA056376 colon, tumor .a 130 to 509 1 to 384     Submitted on the opposite strand 384/393
(97 %)
24 diff
(93.9 %id)
CR989699 T-Lymphocytes .a 133 to 954 1 to 821       821/821
(100 %)
2 diff
(99.8 %id)
BE544462 cervical carcinoma cell line, cervix .a 136 to 668 1 to 534   available from MGC,   534/597
(89 %)
11 diff
(98.2 %id)
BM714097 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 182 to 424 1 to 243   fully sequenced,   243/243
(100 %)
1 diff
(99.6 %id)
BG333786 melanotic melanoma, skin .a 223 to 926 1 to 703       703/704
(99 %)
3 diff
(99.6 %id)
BE563071 endometrium, adenocarcinoma cell line, uterus .a 256 to 959 23 to 718   AAA   696/718
(96 %)
14 diff
(98.1 %id)
BQ956954 brain, neuroblastoma, cell line .a 263 to 961 1 to 699       699/699
(100 %)
3 diff
(99.6 %id)
CN427652 embryonic stem cells, cell lines H1, H7, andH9 .a 287 to 789 1 to 503       503/503
(100 %)
2 diff
(99.7 %id)
BE388197 endometrium, adenocarcinoma cell line, uterus .a 289 to 949 1 to 657       657/747
(87 %)
15 diff
(98.0 %id)
BE393938 endometrium, adenocarcinoma cell line, uterus .a 289 to 576 1 to 288       288/291
(98 %)
3 diff
(99.0 %id)
AW799734 uterus .a 298 to 599 308 to 7       302/308
(98 %)
0 diff
(100 %id)
AW405796 lymph .a 299 to 801 1 to 503       503/503
(100 %)
4 diff
(99.3 %id)
TI_154143231   .a 304 to 819 76 to 594       519/836
(62 %)
5 diff
(99.5 %id)
AA233053 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 354 to 873 5 to 519       515/519
(99 %)
13 diff
(97.5 %id)
BM675280 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 376 to 977 620 to 19   fully sequenced, AAA   602/602
(100 %)
1 diff
(99.9 %id)
H67245 nose, olfactory epithelium .a 394 to 710 1 to 317   fully sequenced,   317/317
(100 %)
6 diff
(98.2 %id)
BG757440 B-cells, primary B-cells from tonsils (cell line) .a 399 to 962 1 to 564       564/750
(75 %)
3 diff
(99.6 %id)
CK823425 Islets of Langerhans, Pancreas .a 404 to 961 568 to 11   AAA   558/558
(100 %)
1 diff
(99.9 %id)
TI_157610850   .a 407 to 961 653 to 95   AAA   559/721
(77 %)
7 diff
(99.1 %id)
BQ028607 placenta, Placenta Choriocarcinoma .a 407 to 961 574 to 19   AAA   556/580
(95 %)
3 diff
(99.5 %id)
AA010129 heart .a 413 to 651 15 to 253       239/253
(94 %)
7 diff
(97.3 %id)
AI741861 pooled .a 428 to 974 547 to 1       547/547
(100 %)
1 diff
(99.9 %id)
AA371992 pituitary gland .a 454 to 728 1 to 275       275/275
(100 %)
3 diff
(99.0 %id)
AW963391   .a 455 to 961 1 to 507   AAA   507/507
(100 %)
4 diff
(99.3 %id)
N42102 melanocyte .a 455 to 723 1 to 269       269/269
(100 %)
5 diff
(98.2 %id)
BM893832 Islets of Langerhans, Pancreas .a 460 to 961 512 to 11   AAA   502/502
(100 %)
1 diff
(99.9 %id)
BF436969 Prostate .a 466 to 961 510 to 16   AAA   495/495
(100 %)
2 diff
(99.6 %id)
BP429005   .a 489 to 828 49 to 391       343/391
(87 %)
7 diff
(98.3 %id)
BM691899 eye, human retina .a 490 to 958 9 to 477       469/477
(98 %)
0 diff
(100 %id)
BM703621 eye, human retina .a 490 to 947 1 to 458       458/458
(100 %)
0 diff
(100 %id)
AA625270 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 497 to 940 1 to 444       444/444
(100 %)
2 diff
(99.6 %id)
AI033494 liver and spleen .a 515 to 973 457 to 1       457/457
(100 %)
4 diff
(99.2 %id)
AW025130 Kidney .a 526 to 962 442 to 6       437/442
(98 %)
0 diff
(100 %id)
BG163845 hypernephroma, cell line, Kidney .a 529 to 961 1 to 433   AAA   433/433
(100 %)
0 diff
(100 %id)
AI870802 anaplastic oligodendroglioma, brain .a 535 to 961 444 to 18   AAA   427/427
(100 %)
11 diff
(97.5 %id)
AI310484 2 pooled tumors (clear cell type), Kidney .a 544 to 961 430 to 13   AAA   418/418
(100 %)
6 diff
(98.6 %id)
EC557838 Prostate .a 547 to 657 1 to 109       109/112
(97 %)
2 diff
(98.3 %id)
AW514788 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .a 555 to 978 428 to 5       424/428
(99 %)
0 diff
(100 %id)
AA056473 colon, tumor .a 556 to 937 387 to 1     Submitted on the opposite strand 387/387
(100 %)
8 diff
(98.0 %id)
AI799541 ovary, tumor, 5 pooled (see description) .a 557 to 973 418 to 1       418/418
(100 %)
3 diff
(99.3 %id)
AI304348 adenocarcinoma, colon .a 589 to 973 391 to 7       385/399
(96 %)
0 diff
(100 %id)
AI017809 Kidney .a 597 to 972 376 to 1       376/376
(100 %)
0 diff
(100 %id)
AI220164 pooled .a 623 to 983 362 to 2   tiling clone,   361/362
(99 %)
0 diff
(100 %id)
BM893714 Islets of Langerhans, Pancreas .a 634 to 961 338 to 11   AAA   328/328
(100 %)
2 diff
(99.4 %id)
AI208430   .a 654 to 961 330 to 23   AAA   308/308
(100 %)
0 diff
(100 %id)
AI470071 pooled .a 678 to 974 297 to 1       297/297
(100 %)
0 diff
(100 %id)
AI560756 anaplastic oligodendroglioma, brain .a 679 to 961 310 to 27   AAA   284/284
(100 %)
2 diff
(99.3 %id)
H81562 nose, olfactory epithelium .a 684 to 937 254 to 1   fully sequenced,   254/254
(100 %)
3 diff
(98.9 %id)
EC510084 Prostate .a 701 to 804 1 to 104       104/104
(100 %)
0 diff
(100 %id)
BI002374 head_normal .a 708 to 962 253 to 4       250/253
(98 %)
0 diff
(100 %id)
AA232686.
matches multiple genes
mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 708 to 978 271 to 1     also hits gene ARRB1 271/271
(100 %)
0 diff
(100 %id)
CD513948 brain, Pituitary .a 725 to 977 30 to 282   AAA   253/282
(89 %)
6 diff
(97.9 %id)
AI131097 heart .a 734 to 962 235 to 7       229/235
(97 %)
0 diff
(100 %id)
EC542478 Prostate .a 735 to 836 1 to 103       103/103
(100 %)
3 diff
(97.1 %id)
AA613314 colon, colon tumor RER+ .a 752 to 962 218 to 9       210/218
(96 %)
0 diff
(100 %id)
CA418955 Chondrosarcoma Grade II, Left Pelvis .a 768 to 961 212 to 19   AAA   194/200
(97 %)
1 diff
(99.5 %id)
AA010130 heart .a 770 to 962 198 to 5       194/198
(97 %)
0 diff
(100 %id)
BF928268 nervous_tumor .a 785 to 921 137 to 1     Submitted on the opposite strand 137/137
(100 %)
1 diff
(99.3 %id)
EC558174 Prostate .a 794 to 892 1 to 97       97/97
(100 %)
5 diff
(94.9 %id)
AA872969 2 pooled tumors (clear cell type), Kidney .a 847 to 961 149 to 35   AAA   115/116
(99 %)
0 diff
(100 %id)
BE407475 choriocarcinoma, placenta .b 1 to 424 1 to 424   tiling clone,   424/712
(59 %)
2 diff
(99.8 %id)
BE275660 melanotic melanoma, skin .b 2 to 317 1 to 315       315/315
(100 %)
1 diff
(99.7 %id)
BE389155 endometrium, adenocarcinoma cell line, uterus .b 2 to 474 1 to 482   tiling clone,   482/559
(86 %)
15 diff
(97.4 %id)
BE386161 melanotic melanoma, skin .b 2 to 580 1 to 587   tiling clone,   587/587
(100 %)
13 diff
(97.8 %id)
BE391313 endometrium, adenocarcinoma cell line, uterus .b 431 to 512 464 to 548   tiling clone,   481/551
(87 %)
18 diff
(96.8 %id)
AK096105 Liver .b 449 to 2106 1 to 1658 exact tiling clone, available from FLJ,   1658/1658
(100 %)
0 diff
(100 %id)
DA637972 Liver .b 450 to 1021 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
TI_59388845   .c 1 to 750 103 to 853 F33L E34S S35P R36G N37I ... tiling clone,   751/751
(100 %)
3 diff
(99.7 %id)
BQ308029 breast .d 1 to 392 30 to 418   tiling clone,   389/422
(92 %)
15 diff
(96.5 %id)
AK000647   .d 34 to 684 1 to 651 exact tiling clone, available from FLJ, AAA   651/651
(100 %)
2 diff
(99.7 %id)
AK225502   .d 34 to 684 1 to 651 exact AAA   651/651
(100 %)
2 diff
(99.7 %id)
TI_57162045   .d 37 to 695 24 to 679 G6E G7A G8A P9L S10P ...     656/679
(96 %)
9 diff
(98.7 %id)
BI832690 pooled pancreas and spleen .d 43 to 695 1 to 650 G6E G7A G8A P9L S10P ...     650/650
(100 %)
4 diff
(99.4 %id)
AA406404 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .d 47 to 545 1 to 498 G8A P9L S10P S11A S12A ...     498/498
(100 %)
5 diff
(99.0 %id)
R48046 breast .d 50 to 392 1 to 350   fully sequenced,   350/350
(100 %)
14 diff
(96.0 %id)
H26714 breast .d 61 to 405 1 to 350   fully sequenced,   350/350
(100 %)
16 diff
(95.5 %id)
H43955 breast .d 62 to 420 1 to 360       360/369
(97 %)
9 diff
(97.6 %id)
BX107311 breast .d 63 to 683 1 to 621 exact     621/621
(100 %)
1 diff
(99.9 %id)
BU178517 eye, retinoblastoma .d 101 to 684 1 to 584 exact tiling clone,   584/584
(100 %)
1 diff
(99.9 %id)
R47937 breast .d 369 to 684 323 to 1   fully sequenced,   323/323
(100 %)
13 diff
(96.0 %id)
H26715 breast .d 375 to 686 313 to 3   fully sequenced,   311/313
(99 %)
15 diff
(95.3 %id)
BM791564 Ascites, stomach .e 1 to 508 44 to 551 exact tiling clone,   508/551
(92 %)
6 diff
(99.0 %id)
BC012080 Skin, melanotic melanoma. Gene C19orf24, variant not shown       available from MGC, AAA Suspected internal deletion, this clone was ignored    
BM018453 astrocytoma grade IV, cell line, brain Gene C19orf24, variant not shown         This clone was ignored    
TI_59389042   Gene C19orf24, variant not shown         This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes C